amlodipine - CISMeF

Preferred Label : amlodipine;

MeSH definition : A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.;

CISMeF synonym : maleate, amlodipine; almirall brand of amlodipine besilate; pfizer brand of amlodipine besilate; mack brand of amlodipine besilate; eczacibasi brand of amlodipine besilate;

MeSH hyponym : norvasc; astudal; amlodipine, (R)-Isomer; amlodipine, ( -)-Isomer, maleate (1:1); amlodipine, ( -)-Isomer; amlodis; Amlodipine Besylate; amlodipine maleate; amlodipine, (S)-Isomer, maleate (1:1); Istin; Amlor; Amlodipine Maleate (1:1);

MeSH CAS label : 3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester;

MeSH Related Number : amlodipine besylate; amlodipine, (S)-Isomer, maleate (1:1); amlodipine, ( -)-Isomer; amlodipine, ( -)-Isomer, maleate (1:1); amlodipine, (R)-Isomer; amlodipine maleate; 111470-99-6 (Amlodipine besylate); 88150-42-9 (Amlodipine); 88150-47-4 (Amlodipine maleate); 103069-18-7; 103129-81-3; 135877-50-8; 135969-53-8; 864V2Q084H; CQ27G2BZJM;

Registry Number MeSH : 88150-42-9;

Related CAS MeSH : 135969-53-8 (Amlodipine, (S)-Isomer, maleate (1:1)); 103069-18-7 (Amlodipine, ( -)-Isomer); 135877-50-8 (Amlodipine, ( -)-Isomer, maleate (1:1)); 103129-81-3 (Amlodipine, (R)-Isomer); 864V2Q084H (Amlodipine besylate); CQ27G2BZJM (Amlodipine maleate);

Wikipedia link : https://en.wikipedia.org/wiki/Amlodipine;

Is substance : O;

UNII : 1J444QC288;

InChIKey : HTIQEAQVCYTUBX-UHFFFAOYSA-N;

Details

Origin ID

D017311;

UMLS CUI

C0051696;

ATC code(s)
- aliskiren and amlodipine [ATC Code]
- aliskiren, amlodipine and hydrochlorothiazide [ATC Code]
- amlodipine [ATC Code]
- amlodipine and celecoxib [ATC Code]
- amlodipine and diuretics [ATC Code]
- atorvastatin and amlodipine [ATC Code]
- atorvastatin, amlodipine and candesartan [ATC Code]
- atorvastatin, amlodipine and perindopril [ATC Code]
- atorvastatin, amlodipine and ramipril [ATC Code]
- benazepril and amlodipine [ATC Code]
- bisoprolol and amlodipine [ATC Code]
- candesartan and amlodipine [ATC Code]
- candesartan, amlodipine and hydrochlorothiazide [ATC Code]
- fimasartan and amlodipine [ATC Code]
- irbesartan and amlodipine [ATC Code]
- irbesartan, amlodipine and hydrochlorothiazide [ATC Code]
- lisinopril and amlodipine [ATC Code]
- losartan and amlodipine [ATC Code]
- metoprolol and amlodipine [ATC Code]
- nevibolol and amlodipine [ATC Code]
- olmesartan medoxomil, amlodipine and hydrochlorothiazide [ATC Code]
- perindopril and amlodipine [ATC Code]
- perindopril, amlodipine and indapamide [ATC Code]
- perindopril, bisoprolol and amlodipine [ATC Code]
- perindopril, bisoprolol, amlodipine and indapamide [ATC Code]
- ramipril and amlodipine [ATC Code]
- ramipril, amlodipine and hydrochlorothiazide [ATC Code]
- rosuvastatin and amlodipine [ATC Code]
- rosuvastatin, amlodipine and lisinopril [ATC Code]
- rosuvastatin, amlodipine and perindopril [ATC Code]
- telmisartan and amlodipine [ATC Code]
- telmisartan, amlodipine and hydrochlorothiazide [ATC Code]
- valsartan, amlodipine and hydrochlorothiazide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Amlodipine maleate (substance) [SNOMED CT concept]
- amlodipine besylate [Substance BNPC]
CISMeF manual mappings
- Amlodipine adverse reaction (disorder) [SNOMED CT concept]
- amlodipine [Substance BNPC]
Currated CISMeF NLP mapping
- Amlodipine [ICD-11 Extension code]
- Amlodipine [SMS substance]
- Amlodipine [NCIt concept]
- Amlodipine (substance) [SNOMED CT concept]
- amLODIPine [LOINC component]
Pharmacological action(s)
- antihypertensive agents [MeSH Descriptor]
- calcium channel blockers [MeSH Descriptor]
- vasodilator agents [MeSH Descriptor]
Record concept(s)
- Amlodipine Besylate [MeSH concept]
- amlodipine [MeSH concept]
- amlodipine maleate [MeSH concept]
- amlodipine, (+-)-Isomer [MeSH concept]
- amlodipine, (+-)-Isomer, maleate (1:1) [MeSH concept]
- amlodipine, (R)-Isomer [MeSH concept]
- amlodipine, (S)-Isomer, maleate (1:1) [MeSH concept]
- amlodis [MeSH concept]
- astudal [MeSH concept]
- norvasc [MeSH concept]
Related MeSH Supplementary Concept(s)
- CJX1, amlodipine derivative [MeSH Supplementary Concept]
- Viacoram [MeSH Supplementary Concept]
- amlodipine nicotinate [MeSH Supplementary Concept]
- amlodipine, atorvastatin drug combination [MeSH Supplementary Concept]
- amlodipine, perindopril drug combination [MeSH Supplementary Concept]
- amlodipine-losartan drug combination [MeSH Supplementary Concept]
- exforge HCT [MeSH Supplementary Concept]
- levamlodipine besylate [MeSH Supplementary Concept]
- telmisartan amlodipine combination [MeSH Supplementary Concept]
- tribenzor [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Amlodipine [NCIt concept]
- Amlodipine (substance) [SNOMED CT concept]
- Product containing amlodipine (medicinal product) [SNOMED CT concept]
- amLODIPine [LOINC component]
- amlodipine [ATC Code]
- amlodipine [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients